Modus Advisors, LLC Abb Vie Inc. Transaction History

Modus Advisors, LLC

$295 Million
Q3 2024

A detailed history of Modus Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Modus Advisors, LLC holds 24,108 shares of ABBV stock, worth $4.23 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

24,108

Previous 23,819 1.21%

Holding current value

$4.23 Million

Previous $4.09 Million 16.52%

% of portfolio

1.61%

Previous 1.49%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$163.84 - $199.33 $47,349 - $57,606	289 Added 1.21%	24,108 $4.76 Million
Q2 2024 Jul 02, 2024	BUY	$154.79 - $180.76 $102,161 - $119,301	660 Added 2.85%	23,819 $4.09 Million
Q1 2024 Apr 02, 2024	BUY	$159.82 - $182.1 $71,919 - $81,945	450 Added 1.98%	23,159 $4.22 Million
Q4 2023 Jan 04, 2024	BUY	$137.6 - $154.97 $67,974 - $76,555	494 Added 2.22%	22,709 $3.52 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $45,554 - $52,735	341 Added 1.56%	22,215 $3.31 Million
Q2 2023 Jul 05, 2023	BUY	$132.51 - $164.9 $144,700 - $180,070	1,092 Added 5.25%	21,874 $2.95 Million
Q1 2023 Apr 04, 2023	BUY	$144.61 - $166.54 $11,858 - $13,656	82 Added 0.4%	20,782 $3.31 Million
Q4 2022 Jan 05, 2023	BUY	$138.31 - $165.87 $30,981 - $37,154	224 Added 1.09%	20,700 $0
Q3 2022 Oct 05, 2022	BUY	$134.21 - $153.93 $4,026 - $4,617	30 Added 0.15%	20,476 $2.75 Million
Q2 2022 Jul 05, 2022	BUY	$137.62 - $174.96 $74,177 - $94,303	539 Added 2.71%	20,446 $3.13 Million
Q1 2022 Apr 05, 2022	BUY	$131.98 - $163.75 $9,106 - $11,298	69 Added 0.35%	19,907 $3.23 Million
Q4 2021 Jan 04, 2022	SELL	$107.43 - $135.93 $66,821 - $84,548	-622 Reduced 3.04%	19,838 $2.69 Million
Q3 2021 Oct 08, 2021	BUY	$106.4 - $120.78 $85,013 - $96,503	799 Added 4.06%	20,460 $2.21 Million
Q2 2021 Jul 01, 2021	SELL	$105.21 - $117.21 $51,237 - $57,081	-487 Reduced 2.42%	19,661 $2.21 Million
Q1 2021 Apr 05, 2021	BUY	$102.3 - $112.62 $186,697 - $205,531	1,825 Added 9.96%	20,148 $2.18 Million
Q4 2020 Jan 08, 2021	BUY	$80.49 - $108.67 $92,724 - $125,187	1,152 Added 6.71%	18,323 $1.96 Million
Q3 2020 Oct 01, 2020	BUY	$85.91 - $100.83 $377,058 - $442,542	4,389 Added 34.34%	17,171 $1.5 Million
Q2 2020 Jul 01, 2020	BUY	$73.37 - $98.18 $299,569 - $400,868	4,083 Added 46.94%	12,782 $1.26 Million
Q1 2020 Apr 08, 2020	BUY	$64.5 - $97.79 $561,085 - $850,675	8,699 New	8,699 $663,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.

Account

Modus Advisors, LLC Abb Vie Inc. Transaction History